Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

In this large cohort, CMR provided several markers of high risk among patients with TR, with TRF thresholds considered by current guidelines as "moderate" TR already associated with worse long-term prognosis. TRF ≥40% was independently associated with both death and heart failure hospitalization. Moreover, L-ECV emerged as a novel imaging biomarker of systemic venous congestion, identifying right heart failure and adding incremental prognostic value to define high-risk patients with TR.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-12
DOI
https://doi.org/10.1161/circulationaha.125.074862
Citations
4
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
5.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

Maurice L. Enriquez-Sarano, Asa Phichaphop, Eustachio Agricola, Miho Fukui et al.
4 citations
Circulation
Cardiac Valve Diseases and Treatments
5.55
article

Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

Maurice L. Enriquez-Sarano, Asa Phichaphop, Eustachio Agricola, Miho Fukui, Davide Margonato, Francesco Maisano, Patrizio Lancellotti, Vinayak Bapat, João L. Cavalcante, Fabien Praz, Jörg Hausleiter, Rebecca Tung Hahn, John R. Lesser, Philipp Lurz, Paul Sorajja, Erik B. Schelbert, Tatsuji Nishihara, Cheng Wang, Ellen Cravero
article en
4 citations

Abstract

In this large cohort, CMR provided several markers of high risk among patients with TR, with TRF thresholds considered by current guidelines as "moderate" TR already associated with worse long-term prognosis. TRF ≥40% was independently associated with both death and heart failure hospitalization. Moreover, L-ECV emerged as a novel imaging biomarker of systemic venous congestion, identifying right heart failure and adding incremental prognostic value to define high-risk patients with TR.

CirculationVol. 152(25)
Valve (United States) (US), Abbott Northwestern Hospital (US), NewYork–Presbyterian Hospital (US), Vita-Salute San Raffaele University (IT), University of Liège (BE), Johannes Gutenberg University Mainz (DE), Columbia University Irving Medical Center (US), University Hospital of Bern (CH), LMU Klinikum (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), German Centre for Cardiovascular Research (DE), Minneapolis Heart Institute Foundation (US), Centre Hospitalier Universitaire de Liège (BE), Cardiovascular Research Foundation (US)
Openalex Percentile: Top 3%
Cardiac Valve Diseases and Treatments
5.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.